Europe bets heavily on Pfizer in vaccine strategy overhaul

15 April 2021 - Europe has hinted it will not renew contracts for coronavirus vaccines produced by pharmaceutical giants AstraZeneca ...

Read more →

Bristol Myers Squibb receives European Commission approval for Opdivo (nivolumab) in combination with Cabometyx (cabozantinib) as first-line treatment for patients with advanced renal cell carcinoma

14 April 2021 - Approval based on Phase 3 CheckMate-9ER trial results showing Opdivo in combination with Cabometyx significantly improved overall ...

Read more →

Public consultation – draft 2021-22 Cost Recovery Implementation Statement for listing medicines on the PBS and designated vaccines on the NIP

15 April 2021 - Consultation on the content of the draft Cost Recovery Implementation Statement for listing medicines on the ...

Read more →

Patient and public involvement in health technology assessment: a new dawn?

12 April 2021 - Patient and public involvement and engagement have become increasingly embedded in health technology assessment over the last ...

Read more →

PhRMA's three part approach to build a better health care system

13 April 2021 - Our plan is based on three key pillars: ending the pandemic and building a more resilient system, ...

Read more →

New blow to rollout as Novavax Covid-19 vaccine hits supply hiccup

15 April 2021 - Australia’s vaccine rollout has been dealt another blow as Novavax confirms manufacturing supply shortages mean it ...

Read more →

Novavax COVID-19 vaccine in Australia: When will we get it? And is it better than Pfizer?

14 April 2021 - Australia's sluggish vaccine rollout was last week thrown another curve ball, with new medical advice recommending ...

Read more →

Petition filed for better access to haemophilia A drug

14 April 2021 - Parents of paediatric patients with haemophilia A are demanding the regulator to change the criteria for ...

Read more →

TGA accepts Telix’s prostate cancer imaging product submission and commences priority evaluation process

14 April 2021 - Telix is pleased to announce that the TGA has accepted the Company’s submission for the registration ...

Read more →

AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets

14 April 2021 - EMA continues to monitor very rare blood clots with low blood platelets that occurred after vaccination ...

Read more →

COVID-19 vaccine Janssen: assessment of very rare cases of unusual blood clots with low platelets continues

14 April 2021 - As announced last week, EMA’s safety committee (PRAC) is reviewing very rare cases of unusual blood clots ...

Read more →

Moleculin awarded new rare paediatric disease designation from U.S. FDA for WP1066 for the treatment of ependymoma

14 April 2021 - Moleculin Biotech announced today that the U.S. FDA has granted rare paediatric disease designation to its ...

Read more →

TGA grants provisional determination to GSK for COVID-19 monoclonal antibody treatment - sotrovimab

14 April 2021 - The TGA has granted a provisional determination to GSK in relation to the monoclonal antibody treatment, ...

Read more →

Tagrisso approved in China in early lung cancer

14 April 2021 - Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk ...

Read more →

Easier access to rare metabolic disorder treatments

14 April 2021 - PHARMAC is making it easier for clinicians to access six treatments for rare metabolic disorders for ...

Read more →